XII Medical is focused on advancing neuromodulation therapies specifically designed for the treatment of obstructive sleep apnea (OSA). The company aims to develop innovative solutions that simplify the treatment process, enhance accessibility for patients, and ultimately improve health outcomes. Their commitment to creating best-in-class therapies reflects a dedication to addressing the complexities associated with OSA, which affects a significant number of individuals.

The technologies being developed by XII Medical are centered around neuromodulation, which involves the use of electrical stimulation to influence nerve activity. This approach is intended to provide effective treatment options that are less invasive and more patient-friendly compared to traditional methods. By leveraging cutting-edge science and engineering, XII Medical seeks to transform the landscape of OSA treatment, making it more efficient and accessible for those in need.

United States

Minimally Invasive Technology for Obstructive Sleep Apnea

Nervous System Diseases

32980 alvarado niles rd, union city, california, united states

XII Medical

XII Medical

Company Details